Skip to main content
Fig. 3 | Critical Care

Fig. 3

From: Post-stroke treatment with argon attenuated brain injury, reduced brain inflammation and enhanced M2 microglia/macrophage polarization: a randomized controlled animal study

Fig. 3

6-Point neuroscore tested daily from 24 h to d7 after reperfusion (a); quantification of brain infarct volume on d7 (b). Significance was indicated with *p < 0.05. tMCAO Ar group displayed significantly improved neurological performance compared to tMCAO N2 group (p = 0.026). Results were represented as mean ± SD, n = 8 for tMCAO Ar group and n = 7 for tMCAO N2 group

Back to article page